参考文献: [1]Kang S H,Lee H W,Yoo J J,et al.KASL clinical practice guidelines:Management of nonalcoholic fatty liver disease[J].Clin Mol Hepatol,2021,27(3):363-401. [2]非酒精性脂肪性肝病防治指南(2018更新版)[J].中华肝脏病杂志,2018,26(03):195-203. [3]Chalasani N,Younossi Z,Lav...
EASL-EASD-EASOClinicalPracticeGuidelinesfortheManagementofNon-AlcoholicFattyLiverDisease / NAFLD纤维化进展 NAFLD是缓慢进行性疾病，20%的肝纤维化会迅速恶化 时间年 肝纤维化进展一阶段用时 在患有动脉高血压的情况下进展速率加倍，针对纤维化伴高血压的NASH患者，应进行更密切的监测 SinghS,...
[39]European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO).EASL-EASD-EASO clinical practice guidelines for t...
[3].UK, N.G.C., Non-Alcoholic Fatty Liver Disease: Assessment and Management. National Institute for Health and Care Excellence: Guidance. 2016, London: National Institute for Health and Care Excellence (UK). [4].Kang, S.H., et al., KASL clinical practice guidelines: Management of nona...
Clinical practiceGuidelinesNAFLDSummary This review of the literature consists of three sections. First, papers concerning non-alcoholic fatty liver disease (NAFLD) awareness among the general population, general practitioners, and liver and non-liver specialists were retrieved and analyzed to highlight ...
[9]European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for ...
NAFLDNAFLD疾病进程疾病进程非酒精性脂肪肝(NAFL)脂肪变性脂肪变性伴轻微小叶炎症非酒精性脂肪性肝炎(NASH)肝细胞癌(HCC)早期NASH:无或轻度(F0-F1)纤维化纤维化NASH:显著(≥F2)或进展性(≥F3)纤维化NASH-肝硬化(F4)EASL-EASD-EASOClinicalPracticeGuidelinesfortheManagementofNon-AlcoholicFattyLiverDisease第3页/共...
12. Cusi K, Isaacs S, Barb D, et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver...
参考文献:[1]Kang S H,Lee H W,Yoo J J,et al.KASL clinical practice guidelines:Management of nonalcoholic fatty liver disease[J].Clin Mol Hepatol,2021,27(3):363-401.[2]非酒精性脂肪性肝病防治指南(2018更新版)[J].中华肝脏病杂志,2018,26(03):195-203.[3]Chalasani N,Younossi Z,Lavine ...
非侵入性诊断的目的在于:指南新增非侵入性诊断方法EASL-EASD-EASOClinicalPracticeGuidelinesfortheManagementofNon-AlcoholicFattyLiverDisease在初级治疗阶段,确定代谢风险增加的个人的NAFLD患病危险在二级和三级治疗中,确认不良的预后监控疾病进展预测对治疗干预因素的应对实现非侵入性诊断目标,减少进行肝脏活检的使用指南对...